Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: M.R. Davis who wrote (12704)	1/15/1999 10:18:00 AM
From: Master Trader	Read Replies (1) \| Respond to of 29382

NSTK nasal Viagra.....good hold for three day weekend Reuters is reporting that two researchers say that they have adapted Pfizer's PFE hugely successful Viagra for nasal delivery that they say works within 5 minutes- up to 12 times faster than the pill form of the anti-impotence drug. "Anwar Hussein, a researcher at the University of Kentucky College of Pharmacy, said he and colleague Lewis Dittert have developed a soluble version of Pfizer Inc's(NYSE:PFE - news) blockbuster drug and want to license it to the pharmaceuticals giant. ''Sometimes patients taking Viagra are embarrassed because they wait an hour or longer and still there's no effect (erection), especially if they've taken the pill with meals,'' Hussein told Reuters. Frustrated patients then sometimes take another Viagra pill in hopes of speeding the effect, a double-dosing that creates the risk of adverse side effects, Hussein said. ''The key was to find how to make Viagra very water soluble so the dissolved drug can be used through the nose,'' Hussein said. Hussein said they hoped to persuade New York-based Pfizer to license their discovery and test it in humans."Our version will be so quick and convenient to use and would definitely be more popular than the pills, which just take too long to work.And it will minimize toxicity by eliminating the urge to double dose,'' he said." Pfizer spokeswoman Mariann Caprino said she was not sure whether the scientists had yet approached company executives with their proposal, or how it might be received." biz.yahoo.com There is one small cap that may capture the market's attention as a way for speculators to get an early jump on the possibility of a Viagra nasal spray.Nastech Pharmaceuticals is recognized worldwide as the foremost leader in nasal drugdelivery. The company has R&D collaborations and commercial partnerships to develop nasal delivery systems with several major pharmaceutical companies, including Bristol-Myers Squibb, Dupont-Merck, and Schwarz Pharma and you guessed ....Pfizer. techmall.com Songwire notes that NSTK already has development for a nasal delivery system for erectile dysfunction already underway - "Nastech recently expanded its product development program to include nasally administered drugs that act via the central nervous system. The company said its initial emphasis will be in the areas of pain management and erectile dysfunction. " biz.yahoo.com In addition,the company has expanded its proprietary franchise in nasal technology to include 10 patents covering the nasal delivery of 65 compounds and an additional 3 patents pending. PFE trading up 114 NSTK trading 4s- low end of its 52 week range of 3-14; expect the market to 'sniff' this one out